Trial Profile
Exploratory investigation of discovering novel biomarker to predict efficacy of chemotherapy including bevacizumab in patients with advanced ovarian cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Jun 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Ovarian cancer
- Focus Biomarker; Therapeutic Use
- 09 Jun 2016 New trial record